Found 560 clinical trials
Pneumococcal Infection
prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease
- 2 views
- 13 Jan, 2022
- 1 location
Pneumococcal Infection
prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), with a 23-valent pneumococcal polysaccharide vaccine for the prevention of pneumococcal disease
- 0 views
- 18 Apr, 2022
- 1 location
COVID-19 Study
We have COVID-19 studies enrolling at ClinSearch, looking at COVID-19 tests, vaccines, and treatment. Help move COVID-19 research forward by enrolling in a research study today. View our FAQ for current COVID-19 trials.
- 34 views
- 23 Mar, 2022
- 1 location
Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)
Popular topic:Clinical trials of the consistency and non-inferiority bridging between batches of recombinant new coronavirus vaccine (CHO cells) Research purpose:Main purpose:1)To evaluate the
- 0 views
- 31 Oct, 2021
- 1 location
Detection of COVID-19 Using Breath Analysis - Validation Study (COVID-19)
DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY
- 0 views
- 04 Oct, 2022
- 1 location
Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19) (COVER-HCW)
Study to support the mental and physical well-being of US health care workers during the COVID-19 pandemic and ensure high-quality care for patients through Stress First Aid.
- 24 views
- 16 Jun, 2022
- 1 location
Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
Multicenter double-blind placebo-controlled parallel-group randomized clinical trial of efficacy and safety of Raphamin in the treatment of coronavirus disease 2019 in outpatients.
- 0 views
- 16 May, 2022
- 13 locations
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19 (MOVe-AHEAD)
The purpose of the study is to assess if the study medication (molnupiravir, MK-4482) will prevent symptomatic coronavirus disease 2019 (COVID-19) in adults who live with someone with confirmed
- 133 views
- 16 Sep, 2022
- 170 locations
JT001 (VV116) for the Early Treatment of COVID-19
The purpose of this study is to evaluate the efficacy, safety and pharmacokinetics of JT001 (VV116) for the early Treatment of Coronavirus Disease 2019 (COVID-19) in participants with mild to
- 6 views
- 24 Apr, 2022
- 2 locations
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
) injection followed by electroporation (EP) using the CELLECTRA™ 2000 device in healthy adult volunteers for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. This study is divided into 2
- 7 views
- 24 Jul, 2022
- 6 locations